Global Insomnia Therapeutics Drugs Market Size, Status and Forecast 2021-2027

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Insomnia Therapeutics Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
  • 1.2.2 Benzodiazepines
  • 1.2.3 Nonbenzodiazepines
  • 1.2.4 Antidepressants
  • 1.2.5 Orexin Antagonists
  • 1.2.6 Melatonin Antagonists
  • 1.2.7 Others
• 1.3 Market by Application
  • 1.3.1 Global Insomnia Therapeutics Drugs Market Share by Application: 2016 VS 2021 VS 2027
  • 1.3.2 Prescription
  • 1.3.3 Over-the-Counter (OTC)
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Insomnia Therapeutics Drugs Market Perspective (2016-2027)
• 2.2 Insomnia Therapeutics Drugs Growth Trends by Regions
  • 2.2.1 Insomnia Therapeutics Drugs Market Size by Regions: 2016 VS 2021 VS 2027
  • 2.2.2 Insomnia Therapeutics Drugs Historic Market Share by Regions (2016-2021)
  • 2.2.3 Insomnia Therapeutics Drugs Forecasted Market Size by Regions (2022-2027)
• 2.3 Insomnia Therapeutics Drugs Industry Dynamic
  • 2.3.1 Insomnia Therapeutics Drugs Market Trends
  • 2.3.2 Insomnia Therapeutics Drugs Market Drivers
  • 2.3.3 Insomnia Therapeutics Drugs Market Challenges
  • 2.3.4 Insomnia Therapeutics Drugs Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Insomnia Therapeutics Drugs Players by Revenue
  • 3.1.1 Global Top Insomnia Therapeutics Drugs Players by Revenue (2016-2021)
  • 3.1.2 Global Insomnia Therapeutics Drugs Revenue Market Share by Players (2016-2021)
• 3.2 Global Insomnia Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Insomnia Therapeutics Drugs Revenue
• 3.4 Global Insomnia Therapeutics Drugs Market Concentration Ratio
  • 3.4.1 Global Insomnia Therapeutics Drugs Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Insomnia Therapeutics Drugs Revenue in 2020
• 3.5 Insomnia Therapeutics Drugs Key Players Head office and Area Served
• 3.6 Key Players Insomnia Therapeutics Drugs Product Solution and Service
• 3.7 Date of Enter into Insomnia Therapeutics Drugs Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Insomnia Therapeutics Drugs Breakdown Data by Type

• 4.1 Global Insomnia Therapeutics Drugs Historic Market Size by Type (2016-2021)
• 4.2 Global Insomnia Therapeutics Drugs Forecasted Market Size by Type (2022-2027)

5 Insomnia Therapeutics Drugs Breakdown Data by Application

• 5.1 Global Insomnia Therapeutics Drugs Historic Market Size by Application (2016-2021)
• 5.2 Global Insomnia Therapeutics Drugs Forecasted Market Size by Application (2022-2027)

6 North America

• 6.1 North America Insomnia Therapeutics Drugs Market Size (2016-2027)
• 6.2 North America Insomnia Therapeutics Drugs Market Size by Type
  • 6.2.1 North America Insomnia Therapeutics Drugs Market Size by Type (2016-2021)
  • 6.2.2 North America Insomnia Therapeutics Drugs Market Size by Type (2022-2027)
  • 6.2.3 North America Insomnia Therapeutics Drugs Market Size by Type (2016-2027)
• 6.3 North America Insomnia Therapeutics Drugs Market Size by Application
  • 6.3.1 North America Insomnia Therapeutics Drugs Market Size by Application (2016-2021)
  • 6.3.2 North America Insomnia Therapeutics Drugs Market Size by Application (2022-2027)
  • 6.3.3 North America Insomnia Therapeutics Drugs Market Size by Application (2016-2027)
• 6.4 North America Insomnia Therapeutics Drugs Market Size by Country
  • 6.4.1 North America Insomnia Therapeutics Drugs Market Size by Country (2016-2021)
  • 6.4.2 North America Insomnia Therapeutics Drugs Market Size by Country (2022-2027)
  • 6.4.3 United States
  • 6.4.3 Canada

7 Europe

• 7.1 Europe Insomnia Therapeutics Drugs Market Size (2016-2027)
• 7.2 Europe Insomnia Therapeutics Drugs Market Size by Type
  • 7.2.1 Europe Insomnia Therapeutics Drugs Market Size by Type (2016-2021)
  • 7.2.2 Europe Insomnia Therapeutics Drugs Market Size by Type (2022-2027)
  • 7.2.3 Europe Insomnia Therapeutics Drugs Market Size by Type (2016-2027)
• 7.3 Europe Insomnia Therapeutics Drugs Market Size by Application
  • 7.3.1 Europe Insomnia Therapeutics Drugs Market Size by Application (2016-2021)
  • 7.3.2 Europe Insomnia Therapeutics Drugs Market Size by Application (2022-2027)
  • 7.3.3 Europe Insomnia Therapeutics Drugs Market Size by Application (2016-2027)
• 7.4 Europe Insomnia Therapeutics Drugs Market Size by Country
  • 7.4.1 Europe Insomnia Therapeutics Drugs Market Size by Country (2016-2021)
  • 7.4.2 Europe Insomnia Therapeutics Drugs Market Size by Country (2022-2027)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic

8 Asia-Pacific

• 8.1 Asia-Pacific Insomnia Therapeutics Drugs Market Size (2016-2027)
• 8.2 Asia-Pacific Insomnia Therapeutics Drugs Market Size by Type
  • 8.2.1 Asia-Pacific Insomnia Therapeutics Drugs Market Size by Type (2016-2021)
  • 8.2.2 Asia-Pacific Insomnia Therapeutics Drugs Market Size by Type (2022-2027)
  • 8.2.3 Asia-Pacific Insomnia Therapeutics Drugs Market Size by Type (2016-2027)
• 8.3 Asia-Pacific Insomnia Therapeutics Drugs Market Size by Application
  • 8.3.1 Asia-Pacific Insomnia Therapeutics Drugs Market Size by Application (2016-2021)
  • 8.3.2 Asia-Pacific Insomnia Therapeutics Drugs Market Size by Application (2022-2027)
  • 8.3.3 Asia-Pacific Insomnia Therapeutics Drugs Market Size by Application (2016-2027)
• 8.4 Asia-Pacific Insomnia Therapeutics Drugs Market Size by Region
  • 8.4.1 Asia-Pacific Insomnia Therapeutics Drugs Market Size by Region (2016-2021)
  • 8.4.2 Asia-Pacific Insomnia Therapeutics Drugs Market Size by Region (2022-2027)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America Insomnia Therapeutics Drugs Market Size (2016-2027)
• 9.2 Latin America Insomnia Therapeutics Drugs Market Size by Type
  • 9.2.1 Latin America Insomnia Therapeutics Drugs Market Size by Type (2016-2021)
  • 9.2.2 Latin America Insomnia Therapeutics Drugs Market Size by Type (2022-2027)
  • 9.2.3 Latin America Insomnia Therapeutics Drugs Market Size by Type (2016-2027)
• 9.3 Latin America Insomnia Therapeutics Drugs Market Size by Application
  • 9.3.1 Latin America Insomnia Therapeutics Drugs Market Size by Application (2016-2021)
  • 9.3.2 Latin America Insomnia Therapeutics Drugs Market Size by Application (2022-2027)
  • 9.3.3 Latin America Insomnia Therapeutics Drugs Market Size by Application (2016-2027)
• 9.4 Latin America Insomnia Therapeutics Drugs Market Size by Country
  • 9.4.1 Latin America Insomnia Therapeutics Drugs Market Size by Country (2016-2021)
  • 9.4.2 Latin America Insomnia Therapeutics Drugs Market Size by Country (2022-2027)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Insomnia Therapeutics Drugs Market Size (2016-2027)
• 10.2 Middle East & Africa Insomnia Therapeutics Drugs Market Size by Type
  • 10.2.1 Middle East & Africa Insomnia Therapeutics Drugs Market Size by Type (2016-2021)
  • 10.2.2 Middle East & Africa Insomnia Therapeutics Drugs Market Size by Type (2022-2027)
  • 10.2.3 Middle East & Africa Insomnia Therapeutics Drugs Market Size by Type (2016-2027)
• 10.3 Middle East & Africa Insomnia Therapeutics Drugs Market Size by Application
  • 10.3.1 Middle East & Africa Insomnia Therapeutics Drugs Market Size by Application (2016-2021)
  • 10.3.2 Middle East & Africa Insomnia Therapeutics Drugs Market Size by Application (2022-2027)
  • 10.3.3 Middle East & Africa Insomnia Therapeutics Drugs Market Size by Application (2016-2027)
• 10.4 Middle East & Africa Insomnia Therapeutics Drugs Market Size by Country
  • 10.4.1 Middle East & Africa Insomnia Therapeutics Drugs Market Size by Country (2016-2021)
  • 10.4.2 Middle East & Africa Insomnia Therapeutics Drugs Market Size by Country (2022-2027)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 Takeda Pharmaceutical Company Ltd.
  • 11.1.1 Takeda Pharmaceutical Company Ltd. Company Details
  • 11.1.2 Takeda Pharmaceutical Company Ltd. Business Overview
  • 11.1.3 Takeda Pharmaceutical Company Ltd. Insomnia Therapeutics Drugs Introduction
  • 11.1.4 Takeda Pharmaceutical Company Ltd. Revenue in Insomnia Therapeutics Drugs Business (2016-2021)
  • 11.1.5 Takeda Pharmaceutical Company Ltd. Recent Development
• 11.2 Vanda Pharmaceuticals
  • 11.2.1 Vanda Pharmaceuticals Company Details
  • 11.2.2 Vanda Pharmaceuticals Business Overview
  • 11.2.3 Vanda Pharmaceuticals Insomnia Therapeutics Drugs Introduction
  • 11.2.4 Vanda Pharmaceuticals Revenue in Insomnia Therapeutics Drugs Business (2016-2021)
  • 11.2.5 Vanda Pharmaceuticals Recent Development
• 11.3 Merck & Co., Inc.
  • 11.3.1 Merck & Co., Inc. Company Details
  • 11.3.2 Merck & Co., Inc. Business Overview
  • 11.3.3 Merck & Co., Inc. Insomnia Therapeutics Drugs Introduction
  • 11.3.4 Merck & Co., Inc. Revenue in Insomnia Therapeutics Drugs Business (2016-2021)
  • 11.3.5 Merck & Co., Inc. Recent Development
• 11.4 Pfizer Inc.
  • 11.4.1 Pfizer Inc. Company Details
  • 11.4.2 Pfizer Inc. Business Overview
  • 11.4.3 Pfizer Inc. Insomnia Therapeutics Drugs Introduction
  • 11.4.4 Pfizer Inc. Revenue in Insomnia Therapeutics Drugs Business (2016-2021)
  • 11.4.5 Pfizer Inc. Recent Development
• 11.5 Teva Pharmaceutical Industries Ltd.
  • 11.5.1 Teva Pharmaceutical Industries Ltd. Company Details
  • 11.5.2 Teva Pharmaceutical Industries Ltd. Business Overview
  • 11.5.3 Teva Pharmaceutical Industries Ltd. Insomnia Therapeutics Drugs Introduction
  • 11.5.4 Teva Pharmaceutical Industries Ltd. Revenue in Insomnia Therapeutics Drugs Business (2016-2021)
  • 11.5.5 Teva Pharmaceutical Industries Ltd. Recent Development
• 11.6 Mylan N.V.
  • 11.6.1 Mylan N.V. Company Details
  • 11.6.2 Mylan N.V. Business Overview
  • 11.6.3 Mylan N.V. Insomnia Therapeutics Drugs Introduction
  • 11.6.4 Mylan N.V. Revenue in Insomnia Therapeutics Drugs Business (2016-2021)
  • 11.6.5 Mylan N.V. Recent Development
• 11.7 Sumitomo Dainippon Pharma Co., Ltd
  • 11.7.1 Sumitomo Dainippon Pharma Co., Ltd Company Details
  • 11.7.2 Sumitomo Dainippon Pharma Co., Ltd Business Overview
  • 11.7.3 Sumitomo Dainippon Pharma Co., Ltd Insomnia Therapeutics Drugs Introduction
  • 11.7.4 Sumitomo Dainippon Pharma Co., Ltd Revenue in Insomnia Therapeutics Drugs Business (2016-2021)
  • 11.7.5 Sumitomo Dainippon Pharma Co., Ltd Recent Development
• 11.8 Sanofi
  • 11.8.1 Sanofi Company Details
  • 11.8.2 Sanofi Business Overview
  • 11.8.3 Sanofi Insomnia Therapeutics Drugs Introduction
  • 11.8.4 Sanofi Revenue in Insomnia Therapeutics Drugs Business (2016-2021)
  • 11.8.5 Sanofi Recent Development
• 11.9 Paratek Pharmaceuticals Inc.
  • 11.9.1 Paratek Pharmaceuticals Inc. Company Details
  • 11.9.2 Paratek Pharmaceuticals Inc. Business Overview
  • 11.9.3 Paratek Pharmaceuticals Inc. Insomnia Therapeutics Drugs Introduction
  • 11.9.4 Paratek Pharmaceuticals Inc. Revenue in Insomnia Therapeutics Drugs Business (2016-2021)
  • 11.9.5 Paratek Pharmaceuticals Inc. Recent Development
• 11.10 Ebb Therapeutics
  • 11.10.1 Ebb Therapeutics Company Details
  • 11.10.2 Ebb Therapeutics Business Overview
  • 11.10.3 Ebb Therapeutics Insomnia Therapeutics Drugs Introduction
  • 11.10.4 Ebb Therapeutics Revenue in Insomnia Therapeutics Drugs Business (2016-2021)
  • 11.10.5 Ebb Therapeutics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer